Surgery Partners, Inc. (SGRY) Financials
SGRY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 6.9 billion | 3.5 billion |
2023-09-30 | 6.8 billion | 6.8 billion |
2023-06-30 | 6.6 billion | 3.9 billion |
2023-03-31 | 6.6 billion | 475.1 million |
SGRY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 42.8 million | 4.5 million |
2023-09-30 | 85.7 million | 4.4 million |
2023-06-30 | 26.3 million | 4.6 million |
2023-03-31 | 50.2 million | 4.2 million |
SGRY Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 43.5 million |
2023-09-30 | 5.8 million |
2023-06-30 | -8.8 million |
2023-03-31 | -26.1 million |
SGRY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 195.9 million | - | 286.5 million |
2023-09-30 | 236.0 million | - | 276.6 million |
2023-06-30 | 177.4 million | 2.5 billion | 301.3 million |
2023-03-31 | 245.5 million | 2.5 billion | 306.8 million |
SGRY Shares Outstanding
SGRY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 19.8 million | - | 97.8 million | - |
2023-09-30 | 18.9 million | - | 109.2 million | - |
2023-06-30 | 25.8 million | - | 31.2 million | - |
2023-03-31 | 24.3 million | - | 32.0 million | - |
SGRY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 735.4 million | 541.8 million |
2023-09-30 | 674.1 million | 508.3 million |
2023-06-30 | 667.6 million | 513.5 million |
2023-03-31 | 666.2 million | 532.2 million |
SGRY
Price: $24.53
52 week price:
Earnings Per Share: -0.09 USD
P/E Ratio: -98.27
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Volume: 772000
Ebitda: 49.2 millionMarket Capitalization: 3.5 billion